QuestionSBA
QuestionChoice
It is not necessary to monitor creatine kinase during anti-hypertensive treatment with calcium channel blockers
34427
c
Creatine kinase
QuestionChoice
It is not necessary to monitor bone profile during anti-hypertensive treatment with calcium channel blockers
34426
b
Bone profile
QuestionChoice
It is generally not necessary to perform routine monitoring during anti-hypertensive treatment with calcium channel blockers apart from asking about adverse symptoms to optimise adherence
34425
a
No routine monitoring is required
QuestionChoice
Calcium channel blockers are not known to cause renal impairment. It is not necessary to monitor renal function during treatment
34429
e
Renal function tests
QuestionChoice
It is not necessary to perform routine ECG monitoring during anti-hypertensive treatment with calcium channel blockers
34428
d
ECG
Concept
Chapter
#### Monitoring

The BNF advises to monitor lung function (in patients with a history of obstructive airway disease).

#### Overdoses

Overdosages with beta-blockers may cause cardiac effects such as bradycardia, hypotension, syncope, conduction abnormalities, and heart failure. Bradycardia is the most common arrhythmia, but some beta-blockers may induce ventricular tachyarrhythmias secondary to prolongation of QT interval (e.g. sotalol) or QRS duration (e.g. propranolol).
Non-cardiovascular effects include central nervous system effects (including drowsiness, confusion, convulsions, hallucinations, and in severe cases coma), respiratory depression, and bronchospasm.

Management
 - Airway protection 
 - Activated charcoal within 1 hour
 - IV Fluids
 
IV glucagon is the first-line management.
 
For symptomatic bradycardia, IV atropine may be used.

2618
2828
CCB side effects
Topic
92
General Practice
6896
Case Presentation: A 67 year old man attends a follow-up appointment at his GP after being discharged from hospital. He had been admitted for three days to manage an acute infective exacerbation of COPD, during which it was noted that his recorded blood pressure consistently ran above 150/90mmHg. The medical team have requested the GP to prescribe antihypertensive treatment.


The GP decides to prescribe amlodipine 5mg PO OD and schedules a follow-up appointment in 2 weeks.

Question: Select the most appropriate option to monitor for adverse effects of this treatment.
a